StockWatch
·
Medical/Dental Instruments
Quarterly ResultAug 5, 2026, 04:31 PM

Sight Sciences Wins $34M Patent Verdict; Q2 Revenue Up 19.6% to $23.4M

AI Summary

Sight Sciences, Inc. reported a significant legal victory, securing a $34 million jury verdict in a patent infringement lawsuit against Ivantis, Inc. and Alcon Inc. The company also announced improved financial results for the second quarter and first half of 2026. For Q2 2026, revenue increased by 19.6% to $23.4 million, and net loss significantly narrowed to $4.4 million. The company maintains sufficient liquidity for at least the next 12 months and is in compliance with debt covenants.

Key Highlights

  • Awarded $34 million jury verdict in patent infringement lawsuit.
  • Q2 2026 revenue increased 19.6% to $23.4 million.
  • Q2 2026 net loss narrowed to $4.4 million from $11.9 million YoY.
  • Six-month revenue increased 16.2% to $43.1 million.
  • Six-month net loss narrowed to $17.4 million from $26.1 million YoY.
  • Cash and cash equivalents totaled $79.8 million as of June 30, 2026.
  • Net cash used in operating activities improved to $12.7 million for six months.
  • $40.0 million outstanding under Hercules Loan Agreement.